90Y-Pentixather | Interleukin Related interleukin-related.com

Product Name :
90Y-Pentixather

Search keywords :
Anditixafortide

drugId :
null

Target Vo:
C-X-C motif chemokine receptor 4

Target Vo Short Name :
CXCR4

Moa_Name:
C-X-C motif chemokine receptor 4 modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of Wurzburg

Active Company_Name :
Pentixapharm AG

Active Indication_Name:
Central Nervous System Lymphoma

In Active Indication_Name:
Multiple Myeloma

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
OGT Rabbit mAb Biological Activity
Astegolimab Immunology/Inflammation
Neomycin Antibody (YA907): Neomycin Antibody (YA907) is an unconjugated, rabbit-derived, anti-Neomycin (YA907) monoclonal antibody. Neomycin Antibody (YA907) can be used for: ELISA expriments in background without labeling.

Author: Interleukin Related

Related Posts